Fatal Fulminant Hepatitis from Rituximab-induced Hepatitis B Reactivation in a Patient with Follicular Lymphoma: A Case Report and a Brief Review of Literature

The objective of our study was to recognize hepatitis B reactivation as a complication of rituximab chemotherapy and to realize the importance of screening for prior Hepatitis B virus (HBV) exposure in all patients with hematologic malignancies who will receive rituximab as part of their therapy. Ri...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Zarak H, Ilyas, Kamran, Ghazanfar, Haider, Khan, Hamza H, Hussain, Qulsoom, Hammad, Sahla, Munir, Ahmed, Asim, Rizwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2018
Materias:
Family/General Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931408/
https://www.ncbi.nlm.nih.gov/pubmed/29725560
http://dx.doi.org/10.7759/cureus.2257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931408/
https://www.ncbi.nlm.nih.gov/pubmed/29725560
http://dx.doi.org/10.7759/cureus.2257

Ejemplares similares